Pentagon temporarily rescinds guidance on testosterone screening for US troops
BLUF – The Pentagon temporarily rescinded newly issued clinical guidance for mandatory testosterone-deficiency screening of service members age 30 and older, saying the document requires updates while interim guidance remains in effect; the withdrawn guidance had established separate screening and treatment pathways for men and women during annual health assessments. For Navy Medicine, the reversal creates near-term uncertainty for clinicians responsible for implementing the new hormone-screening policy and highlights the need to follow updated DHA guidance as screening, diagnostic and treatment requirements are refined.